CAMBRIDGE, Mass., Sept. 26, 2018 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at CantorFitzgerald's Global Healthcare Conference on Wednesday, October 3, 2018, at 5:10 p.m. ET at the Intercontinental New York Barclay Hotel in New York, NY. A live
About InfinityInfinity is an innovative biopharmaceutical company dedicated to advancing novel cancer treatments. Infinity is advancing IPI-549, a potentially transformative immuno-oncology approach that aims to reprogram tumor-associated macrophages by selectively inhibiting PI3K-gamma. A Phase 1/1b study in approximately 200 patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.
Contact:Stephanie Ascher, Stern Investor Relations, Inc.212-362-1200 or Stephanie@sternir.com
View original content:http://www.prnewswire.com/news-releases/infinity-to-present-at-cantor-fitzgerald-global-healthcare-conference-300719031.html
SOURCE Infinity Pharmaceuticals, Inc.
Subscribe to our Free Newsletters!